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SPREAD  THE SCIENCE NOT THE VIRUS:CLINICAL LESSONS FROM THE NORTHEAST SURGE
• Between early March and July 18th 2020 approximately 406,807 New Yorkers 
have tested positive for  COVID-19  ( 5,115,470 have had testing)                                      
( 7.9% positivity rate  overall )  48.7% are female.
• In New York as of July 18th there have been 25,056 deaths
(overall 6.16 % fatality rate)  (42% of fatalities are female)
• Of  these fatalities 90% have has at least ONE CO-MORBIDITY 
• Major Co-Morbidities are:
• Hypertension   (53%)                                                 
• Diabetes  (35%) 
• Dyslipidemia (21%) 
• Dementia (13.5%) 
• CAD (11.7%)
• CKD ( 10.4 %)
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EDTA-ERA :  COVID-19 AND ESKD
: 
US (n= 11)
AKI in hospitalized patients, n/N (%) 4747/15154   (31.3%)
Range across cohorts 18.9%-69.0%
AKI in ICU patients, n/N (%) 2352/4244     (55.4%)
Range across cohorts 31.6%-100%
RRT in hospitalized patients, n/N (%) 987/15546     (6.3%)
Range across cohorts 4.8%-15.4%
RRT in ICU patients, n/N (%) 386/2304       (16.8%)
Range across cohorts 11.3%-51.4%
CKD in hospitalized patients, n/N (%) 1558/15131   (10.3%)
Range across cohorts 5.0%-38.0%
Kidney-related outcomes and 
underlying disease among COVID-19 
patient cohorts in the US, January to 
May 2020 
SHANNON NOVOSAD, MD, MPH
Lessons Learned: Outpatient Dialysis
• Come to dialysis
• Call in ahead of your treatment if you are have fever, cough, etc.
• Protect yourself at home: face covering, social distancing, hand washing
• If you are sick: don’t just tough it out at home: call your doctor. Come to 
hospital
• Hemodialysis facility lessons
• Transportation: anticipate and educate
• Segregate proven COVID-19 and PUI
• Screen patients and staff every shift: questions, temp 
• No waiting rooms
• Mental health resources
• Prepare for the long haul (staff shortages, staff health, PPE)
This Photo by Unknown Author is licensed under CC BY-NC-ND
CDC: Return to Outpatient Dialysis (July 2020)
No Test-Based Strategy for Discontinuing Transmission-Based Precautions
Symptom-Based Strategy for Discontinuing Transmission-Based Precautions.
Patients with mild to moderate illness who are not severely immunocompromised:
At least 10 days have passed since symptoms first appeared and
At least 24 hours have passed since last fever without the use of fever-reducing medications and
Symptoms (e.g., cough, shortness of breath) have improved
Note: For patients who are not severely immunocompromised1 and who 
were asymptomatic throughout their infection, Transmission-Based Precautions may be 
discontinued when at least 10 days have passed since the date of their first positive viral diagnostic 
test.
Patients with severe to critical illness or who are severely immunocompromised1:
At least 20 days have passed since symptoms first appeared and
At least 24 hours have passed since last fever without the use of fever-reducing medications and
Symptoms (e.g., cough, shortness of breath) have improved




New York City Dialysis Community Audit






















72 114 253 414
# ICU Beds Mid
COVID-19
243 35 376 144 260 433 800
% Increase in # 
of ICU Beds
145.45% --- --- 100.0% 128.07% 71.15% 93.23%
% ICU Patients 
COVID-19 +
92.5% 57.1% 100% 79.7% 92.3% 97.4% 91.3%
% ICU COVID-
19 + Patients 
on RRT
27.1% 65.0% 23.7% 56.2% 27.1% 19.5% 30.5%
ASN Analysis of 7 Hospital Systems, Greater NY
• At the height of the COVID-19 pandemic in NYC, many 
hospital systems feared they did not have enough CRRT 
fluids.
• Needs for CRRT and other RRT were ”burning through” up to 
5 times the usual supply of fluids, cartridges, other supplies
• Staffing shortages threatened to limit ability to deliver RRT
• More ICU nurses, dialysis nurses and technicians were needed
• ICU nurses, dialysis nurses and technicians were falling ill and 
numbers fell 
• Wide variation in actual CRRT fluid used (30-70 
liters/patient/day); due to the impending fluid 
shortages
• Teams were creative in seeking alternative RRT 
therapies
• Reducing the volume of CRRT fluid delivered/patient
• Using intermittent rather than continuous treatments’
• Utilizing intermittent hemodialysis, sustained low 
efficiency dialysis (SLED), or acute peritoneal dialysis for 
many patients
Increasing nursing staffing for 1:1 treatments 
and staff shortages due to illness or quarantine
CHALLENGES DURING COVID CRISIS  
Dr. Michele Mokrzycki, Montefiore Medical Center, Bronx, NY
• 2 of the 7 hospitals actually had fluid shortages of 
between 3,000 and 9,000 liters for the week
• 5 of 7 had ideal fluid need shortages of between 
1,000 and 31,000 liters were they to use 70L/pt/day 
for CRRT. 
• 2 of 7 had ideal fluid need shortages were they to use 
60L/pt/day for CRRT
• Conservation of dialysis fluids and equipment have to
be closely balanced with patient safety
FINDINGS
Where are we now?
• Most hospitals now have sufficient PPE
• Hospital beds and ICUs are filling up in new hotspots: 
Phoenix, Houston, Miami
• ICU utilization appears lower than                                       
March-April in NY
• AKI and RRT appear less prevalent                                           
than in March-April in NY
• Staffing remains a challenge
This Photo by Unknown Author is licensed under CC BY-ND
Right time PD in Covid-19, 
not running of time PD 
Leslie P. Wong, MD, MBA
Chief Medical Officer, Nephrology Care Alliance
Chair, Quality Improvement and Education, ASN-NTDS
Staff Nephrologist, Cleveland Clinic
Disclosures
• Employee of Nephrology Care Alliance and 
Cleveland Clinic
• My presentation and opinions are my own and do 
not represent the view or position of my employers, 
nor should they be treated as specific medical 
advice
Consideration #1: 
Resource (and nephrologist) stress at all levels
20-25% ventilated Covid-19 patients 
require RRT in reports across Europe and 
the U.S.1
Columbia University Division of Nephrology, JASN 2020, 31(7) 1371-1379
1 ISN-ISPD AKI webinar May 6, 2020 
Machine, supply chain, and staffing 
shortages force rationing of RRT 
services.
Consideration #2: 
Is PD a solution for AKI in Covid-19?
Not enough cyclers or PD nurses!Less infrastructure/cost, simplicity1
More gradual solute and fluid removal1
No anticoagulation and avoidance of BSI1
Little or no difference in mortality1
ARDS and cytokine storm!
No benefit if no PD catheter!
That was in Brazil!
1 Cochrane Database Syst Rev. 2017 Dec 4;12:CD011457.
Consideration #3: 
































Concerns are magnified by lack of experience in U.S. ICU settings
Consideration #4: 
Acute PD isn’t the same as urgent start PD
• Urgent start PD is usually 6-8L/d
• Acute PD studies used 36-44L/d
• AKI in the ICU is not new ESKD
• During initial 24 hours, short cycle 
times may be needed to more 
rapidly achieve solute/fluid 
targets
• Solution and cycler supply stress?
2014 ISPD Guidelines
Sample protocol: ISPD 2020 AKI Guidelines
• Much simplified protocol
• This regimen is continued 
until the patients acute RRT 
indications are stabilized
• 2.5% and 4.25% solutions 










< 60kg 1.5L 120 min 12
60-80kg 2L 120 min 12
80-100kg 2L 90 min 16
From Brett Cullis, ISN-ISPD Webinar April 23, 2020
Sample protocol: King’s College, U.K.
https://renal.org/wp-content/uploads/2020/04/KCH-Renal-Covid-Acute-PD-on-ICU-protocol-final.pdf
Consideration #5: 












? ? ? ? ? ?
AKI Lack of CRRT/HD Delayed PD Outcomes?
AKI Early PD Rescue CRRT/HD Outcomes?
AKI ? ? Outcomes?
Treatment of Kidney Disease During 
the COVID-19 Pandemic
David M. Charytan, M.D. M.Sc.
Norman S. Wikler Associate Professor of Medicine




• NIDDK, NHLBI, Medtronic, 
• Gilead, Amgen (pending), Novo Nordisk
• Consulting
• Medtronic, Lilly, Janssen, Boehringer, Gilead, Novo Nordisk, 
and Fresenius, AstraZeneca
• Data safety monitoring board/clinical endpoint 
committee




• Janssen and Zoll

Impediments to delivery of adequate KRT
• High incidence of AKI in affected patients
• Loss of hemodialysis personnel to COVID-19
• Relative inexperience of some personnel with placement of 
peritoneal dialysis catheters
• Relative inexperience of ICU staff and dialysis staff with performance 
of peritoneal dialysis
• Shortages of supplies of KRT supplies




• Conventional HD machine, HD nurses
• CVVH: Continuous venovenous hemofiltration
• Slower, indicated for hemodynamically unstable people
• Usually performed by ICU nurse
• Peritoneal dialysis
• Recently out of favor in New York
• Slow, continuous 















• Surgical vs. IR vs. Nephrology vs. Critical Care
• Bedside vs. OR
• Laparoscopic (? Superspreading) vs. direct visualization






• Patient selection 
• Catheter Insertion Protocol
• PD prescription 
• ICU education
Creating an Acute PD Program 
Considerations
• PD Technicians-does not need to be nursing-Bellevue program used PAs and 
redeployed ophthalmology and dermatology MDS
• Those familiar with sterile technique can learn manual PD basics in < 60 minutes












• Catheter Insertion-need a clear line of command/good communication
• Daily review of lists and contact with proceduralist
• Coordination with Supply Chain
• Detailed lists of all supplies and expected needs




• Direct visualization with minimal dissection 
• Flexible, double-cuffed catheters
• Lateral placement to help with proning
• The cuff is secured to the posterior fascia with a 
stitch




• Prior lower abdominal surgery (relative 
contraindication) 
• Known abdominal adhesions
• Hyperkalemia >6.5 mEq/L refractory to medical 




• Stage 5 progressing to ESRD
• AKI patients who have initiated HD or CVVH 
without contraindication for PD and expected to 
have a prolonged hospital stay (unloading the 
HD/CRRT service)
• Last choice--admitted ESKD patients on HD
PD Rx
• Initial protocol
• Flush with 500 cc x3
• 500 cc x 2 hours—2.5%
• Increase by 250 cc/fill every 2-3 exchanges for first 6 then by 
500/exhange
• Target 2L/exchange within 48-72 hours
• Heparin in initial exhanges
• Dwell time 2 hours with 5-8 exchange/day
• Reduce volume or hold 12 hours for leaks
• Gent to exit site
• Adjust prn needs
• Transfer to cyclers when available—17-20L exchange 
volume
Keys to Success
• Multi-disciplinnary engagement in program development
• Clear education plan, stepwise progression from manual to 
cyclers
• Daily review of eligible patients with direct communication 
between proceduralist and nephrologist 
• Nephrologist led daily PD rounds with PD “nursing” team, ICU 
team and nephrology staff
Manual PD vs. Cyclers
A 12-foot cycler standard drain line extension (life hack) can extend from usual PD catheter 
transfer set by 12 feet (Baxter only). A second transfer set is attached at the end of the extension. 
Multiple extenders can fit together so it can be even 24 ft. 
Peritoneal dialysis at Bellevue 
• Peritonitis: 0 
• Non-functioning catheter, converted to HD: 1
• Catheters requiring revision-2
• Successfully dialyzed: 35
• (2 improved before treatment initiated)
• Received PD while in prone position: 7
• BMI<30: 13; BMI 30-40: 18; BMI > 40: 4
• Leaks-9, all transient and managed conservatively—none required stopping PD
Courtesy Dr. Nina Caplin
Outcome Male Female Total
Patient who received PD catheters 29 10 39
Recovered prior to starting PD 1 0 1
ESKD 1 1 2
Recovered and had catheter removed* 9/27 (33%) 5/9 (56%) 14/36(39%)
Expired on PD 20/28 (71%) 4/10 (40%) 24/38 (63%)
Average age of all patients (years) 59.5 66.2 59.5
Average age, recovered patients 56 59.5 57.6
Average age, expired patients 71.8 62.3 60.6
Challenges
• Despite success-bias remains against PD as an inferior, 2nd choice therapy
• Surgical team less available now that elective procedures have resumed
• Nursing redeployed
COVID-19:
critical illness and AKI




Professor, Surgery and Medicine 
Mt Sinai School of Medicine 
coritsg@nychhc.org
First ~ 200+ symptomatic COVID 19 positive patients 
admitted to Elmhurst Hospital Center March - April.
Coronavirus disease 2019 (COVID-19) 
From mid-March through early May, 2020, New 
York City was the epicenter of the United States 
outbreak. 
 For NYS, > 400,000 confirmed cases, with > 32,000 deaths 
 2/3 from in NYC
 Elmhurst Hospital Center is a public, 450 bed hospital in Queens, which 
cares for a large immigrant population primarily from central and south 
America but from Asia as well 
 In these first weeks, we and physicians from other 
NY centers, witnessed an inordinate amount of 
respiratory failure and ARDS; often accompanied 
by an impressive development of AKI 
 older adults with comorbidities such as diabetes mellitus and 
cardiovascular disease were at highest risk of hospitalization, ICU 
admission, and death 
Early AKI Demographics: 
first 200+ COVID (+) patients admitted
AKI (98) Non-AKI 
(118)
p-value
Age 60.62 57.55 0.18
BMI 29.4 20.07 0.78
Male (%) 81.96 80.89
0.86
Female (%) 18.03 19.1
HTN 65 58 0.011
Diabetes 45 47 0.37
Hispanic (%) 57.37 65.16 0.33
Asian (%) 29.5 17.97 0.09
Black (%) 4.91 5.61 0.85
White (%) 8.19 11.23 0.05
Undocumented 22 14 0.018







Na 136 136 0.72
K 4.4 4.4 0.56
Bicarb 20 22 0.0004
Ca 8.1 8.3 0.011
Phosphate 3.4 3.6 0.73
BUN 23 15 0.0003
Creatinine 1.17 .96 0.009
Albumin 3.6 3.8 0.0001
Ferritin 1052.5 986 0.593
Hemoglobin 13.28 13.23 0.89
WBC 10.4 9.16 0.09
CPK 256 172 0.08















Procalcitonin .265 .445 0.005
IL-6 79.2   117 0.0112
CRP 133   218 0.0002
LDH 480.5 623 0.0001
D-Dimer 384 475 0.038





Procalcitonin .43 2.39 0.0001
IL-6 119.8 235.6 0.0065
CRP 196.6   300 0.0001
LDH 526.5 711 0.0001
D-Dimer 879 5855.5 0.0001
Early AKI vs non-AKI
Almost all patients had some urinary 
WBCs; 
Bicarb and albumin levels were lower on 
admission; BUN and creatinine higher
LDH, procalcitonin, d dimers and CRP 
were higher in AKI; which continued to 
increase
76% required ventilator assistance 
Management
Potassium control
 control of Acidemia –earlier bicarbonate use during permissive 
hypercapnia
 Feed –permits insulin production
 Binders – zirconium





Lower DFRs used  
 Combination with multiple days
COVID AKI at Elmhurst: 
acute renal replacement therapy (RRT)
First week of April
Ordinarily the hospital has 10 – 12 patients per 
week receiving for 30 – 40 RRTs. 
118 patients were placed on hemodialysis or 
sustained low efficiency daily dialysis (SLEDD) 
represents ~ 30-40 admitted patients
17 patients/day had RRT
COVID AKI at Elmhurst: 
acute renal replacement therapy (RRT)
Month of April
The peak week had over 50 patients requiring 
RRT
An average 24 patients/day were placed on 
hemodialysis or sustained low efficiency daily 
dialysis (SLEDD)
on average ~1/3 were ESRD or 5 ESRD patients 
per day 
~46% of AKI patients were placed on SLEDD or 
low flow dialysis
Outcomes: first 200+ COVID (+) patients admitted
AKI (98) Non-AKI (118) p-value
Days to Death 9.94 8.57 0.16
Mortality (%) 73 21 <0.0001

















 on average ~1/3 were ESRD or 5 ESRD patients per day 
Hospitalization Death
OR(CI95) P-value OR(CI95) P-value
Borough/City
Manhattan 1 1
Queens 2.4 (1.0-5.7) 0.05 1.6 (0.6-4.9) 0.4
Brooklyn 1.8 (0.7-4.4) 0.3 2 (0.7-6.1) 0.2
Bronx 1.8 (0.6-5.2) 0.2 2.3 (0.7-8.2) 0.2
Long Island 1.6 (0.5-5.2) 0.4 1.8 (0.5-7.0) 0.4
Gender
Female 1 1
Male 0.7 (0.4-1.2) 0.2 1.3 (0.8-2.2) 0.3
Race/ethnicity
White 1 1
Black 0.5 (0.2-1.1) 0.1 1.1 (0.4-2.6) 0.9
Hispanic 0.5 (0.2-1.2) 0.1 1.0 (0.4-2.3) 0.9
Asian 0.4 (0.1-1.0) 0.06 1.4 (0.5-3.9) 0.5
Multiracial or other 0.4 (0.03-4.0) 0.4 2.8 (0.2-30.3) 0.4
SSN
No 1 1
Yes 1 (0.6-1.8) 0.9 0.4 0.004*
Age
18-44 1 1
45-54 1.2 (0.4-3.0) 0.7 0.9 (0.2-3.8) 0.9
55-64 0.8 (0.3-1.8) 0.5 2.4 (0.7-8.4) 0.2
65-74 0.8 (0.3-1.7) 0.5 3.4 (1.0-11.3) 0.05
75 or older 1.2 (0.5-3.0) 0.6 7.4 (2.2-24.8) 0.001*
ESKD Vintage 1 (0.9-1.0) 0.3 1.1 (1.01-1.14) 0.01*
Diabetes
No 1 1
Yes 1.3 (0.8-2.0) 0.3 1.2 (0.8-2.1) 0.4
Hypertension
No 1 1
Yes 0.9 (0.6-1.4) 0.7 0.8 (0.5-1.3) 0.3
CHF
No 1 1
Yes 0.8 (0.4-1.4) 0.4 1.8 (0.9-3.4) 0.1
CAD
No 1 1
Yes 0.7 (0.4-1.3) 0.3 1.3 (0.7-2.5) 0.5
• Risk factors for hospitalization and death 
of a COVID-19(+/S) cohort. The non-
adjusted odds ratio (OR) and the 95% 
confidence interval (CI95) is indicated 
for each outcome
• 2,178 dialysis patients were screened 1st
month:
• 306 were COVID-19(+/S) and ~80% (n=244) 
confirmed positive COVID-19
• Common signs/ symptoms of COVID-19; fever (44%), 
cough (28%), weakness/fatigue (20%)
• an incidence of 111 per 1,000 dialysis patients 
(overall population NYC rate of 25 per 1,000) 
• Hospitalizations:178 (58%), 8% of total SDO
• Patients residing in Queens had significantly 
increased odds of hospitalization (OR 2.4, 95%CI 
1.0-5.7). 
• likely reflects the high Queens population 
density 
• Deaths 85 (28%) in the COVID-19(+/S) 
cohort; 4% of the total SDO
• The expired were older (70, SD: 11.9), had a higher 
ESKD vintage at 5.5 (SD: 4.4) years and a higher 
male %. 
• Hospitalized deaths (26.8%) vs not 
hospitalized (28.9%), not significantly 
different 












01/24/2019 to 03/07/2019 01/24/2020 to 03/07/2020 03/08/2019 to 04/20/2019 03/08/2020 to 04/20/2020
Comparison of Hospital/ ED Visits and Mortality Counts to Periods 
Before Pandemic COVID-19
# of Hospitalized # of ER Visits # of Expired
2019 20192020 2020







GNYHA WebinarJuly 21, 2022
COVID-19:
Acute Kidney injury Response
Patient Volume
• Between March 26 and April 24, hospital systems in New York City 
double ICU bed capacity.
• At baseline, 5-10% of patients in ICUs require dialysis by multiple 
reports.
• Acute kidney injury complicates at least half of cases of COVID-19 
requiring ICU care.
• Estimates indicate that 25-90% of patients in ICUs are receiving renal 
replacement therapy: most receive continuous dialysis therapies.
• The volume of patient receiving continuous dialysis increased 
approximately 5X over this time period.
Continuous Dialysis Therapies
• Due to the expanded need for treatments, concerns arose that there 
would be inadequate supply of machines, fluids and trained staff to 
provide continuous therapies.
• To ensure that all patients received sufficient therapy to provide 
metabolic and volume control, physicians found innovative solutions:
– Reduced Dialysate Flow Rates
• Standard CRRT uses 50 mL/min (72 L.day)
• Reduced flow CRRT can be done at 15 mL/min (21.6 L/day)
– Prolonged Intermittent Renal Replacement Therapy (PIRRT)
• Depending on individual metabolic needs, patients are 
treated for 8-12 hours daily.
• Machines can be used to treat 2-3 patients each day.
Addressing Fluid Shortages
• After about three weeks of this level of increased capacity, many hospital 
systems in New York became concerned that they would not have sufficient 
fluid to treat patients in the coming days.
• The American Society of Nephrology’s COVID-19 Response team convened 
a meeting with the clinical leadership of Northwell, NYC HHC, NYU, New 
York-Presbyterian, Mount Sinai, Albert Einstein and New York Medical 
College.
• Information was distributed to:
– Manufacturers (Baxter and NxStage/Fresenius)
– The Federal Government (ASPR, CMS and FDA)
– Via the Greater New York Hospital Association to Governor Cuomo
• Additional fluids, machines and staff were brought to avert crisis
70
AKI in COVID-19
Westchester Medical Center Experience
July 21, 2020
AKI in COVID-19
Westchester Medical Center Experience
• Between early March and early June  approximately 246  patients with confirmed 
(tested positive)  COVID-19 were diagnosed with  AKI at  Westchester Medical 
Center.  “Mild /moderate” ( KDIGO 1/2)  AKI cases may not have been recorded 
• Of  these  (PRELIMINARY coded data through June 2020
• 80 patients  ( 32 % of patients with AKI)  required dialysis support . The vast  majority received CRRT  
• Survival rate among  COVID 19 positive ICU patients with AKI was  52%  ( discharged ).
• Survival among COVID-19 who required dialysis 25% 
• Survival  among  COVID-19 AKI patients who did not receive or  require HD  65% 
71
72
• Approximately 50-55 patients at any point in time required simultaneous RRT.
• ICU population LOS was about 95 -105 most days.
• About 20 patients were typically maintained on CVVHD-choice largely based on 
hemodynamic instability and staffing availability (CRRT initiated by hemodialysis staff; 
maintained by ICU). Average age 60.6; 82% male.
• Under normal circumstances typical dialysate use is approximately 50 to 70 L/day/pt
• Dialysis prescription changed  to mix of CVVHDF and CVVHD due to fluid shortages.
• Prescription changed to 1-1.5  L/h of dialysate and 500 cc/h of convective clearance 
using Plasma-Lyte, NS, or Lactated Ringers depending on patient’s pH and fluid 
availability.
• If potassium under  4.5  Ringer’s Lactate  used;  if potassium over  4.5 bicarb or saline 
used depending upon the pH.
• Typically if pH under 7.30-7.35  used bicarbonate based(D5W or 0.45NS and  bicarb) 
with bicarbonate adjusted based on pH.
• Total CVVHD Clarence typically maintained at 20-25 ml/kg/hr.
AKI in COVID-19
Westchester Medical Center Experience
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AKI in COVID-19
Westchester Medical Center Experience
• Hyperkalemia routinely present, related to marked shortage of K2 dialysate 
and catabolic state-majority of patients received binders including sodium 
zirconium, and occasionally  kayexalate; bicarbonate drip, insulin and D50  
routinely utilized.
• System clotting was a major issue most patients were maintained on full 
dose heparin anticoagulation. Argatroban used if HIT suspected.
• Remaining patients maintained on routine hemodialysis - times typically  2-
1/2-3 hours due to patient volume and staff availability. Typically performed 
HD close to 24 hours/day 
• Fluid clearance took precedence over solute clearance-typical BUNs about 
30-50 points higher than routine HD patients.
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Spread the Science, NOT the Virus
Clinical Lessons from the Northeast Surge Series
Next Week: Obstetrics and Birthing During COVID-19
7/28/20 4:00 pm ET | Register Here
Featuring:
Katherine Campbell, MD, MPH, Yale New Haven Hospital
Dena Goffman, MD, New York Presbyterian Hospital and Columbia University Medical Center
Christian Pettker, MD, Yale New Haven Hospital
Blair Wylie, MD, MPH, Beth Israel Deaconess Medical Center
Weekly Webinar recordings can be found at Jefferson Digital Commons: 
https://jdc.jefferson.edu/covid-19-ssnv
For more information or questions visit our website 
or contact Mary.R.Cooper@Jefferson.edu. 
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